Ann: Trading Halt, page-47

Everyone needs to chill. The AGM is today, so more info might be provided then and then the company will release to market.

Don't we think it's funny we had a groundbreaking announcement yesterday, that Zantrene protects the heart from SOC chemo drugs, and then there is this announcement? Dr T has always stated they don't raise funds just for the sake of having a large pool of capital to use, they use it to progress trials and move faster. I think it is a good sign this is happening, could be a partnership announcement tacked onto it. Maybe BP couldn't wait, *cough* pfizer *cough* haha that their chemo drugs have now become even more competitive if paired with Zantrene. I know from a strategic perspective, I'd seriously be looking at extending this internal capability. Think about how much more you could charge for the treatment and how much less insurance companies would have to pay out due to heart damage...